Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Donev, Rossen M.
Gray, Lisa C.
Sivasankar, Baalasubramanian
Hughes, Timothy R.
van den Berg, Carmen W.
and
Morgan, B. Paul
2008.
Modulation of CD59 Expression by Restrictive Silencer Factor–Derived Peptides in Cancer Immunotherapy for Neuroblastoma.
Cancer Research,
Vol. 68,
Issue. 14,
p.
5979.
Voss, Stephan D.
2009.
Oncology of Infancy and Childhood.
p.
1015.
Yamane, Brett H
Hank, Jacquelyn A
Albertini, Mark R
and
Sondel, Paul M
2009.
The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma.
Expert Opinion on Investigational Drugs,
Vol. 18,
Issue. 7,
p.
991.
Behrends, Uta
and
Mautner, Josef
2009.
Tumor‐Associated Antigens.
p.
113.
Gardner, Sharon L.
Ahmed, Nabil
and
Okada, Hideho
2010.
Immunotherapy for Pediatric Central Nervous System Tumors.
Biology of Blood and Marrow Transplantation,
Vol. 16,
Issue. 1,
p.
S75.
Mazur, Kate A.
2010.
Neuroblastoma: What the nurse practitioner should know.
Journal of the American Academy of Nurse Practitioners,
Vol. 22,
Issue. 5,
p.
236.
Zage, Peter E.
Louis, Chrystal U.
and
Cohn, Susan L.
2012.
New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.
Pediatric Blood & Cancer,
Vol. 58,
Issue. 7,
p.
1099.
Ladenstein, Ruth
Weixler, Silke
Baykan, Bianca
Bleeke, Matthias
Kunert, Renate
Katinger, Dietmar
Pribill, Ingrid
Glander, Petra
Bauer, Steffen
Pistoia, Vito
Michon, Jean
Garaventa, Alberto
and
Lode, Holger N.
2013.
Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients.
mAbs,
Vol. 5,
Issue. 5,
p.
801.
Goswami, Sumit
Wang, Wei
Arakawa, Tsutomu
and
Ohtake, Satoshi
2013.
Developments and Challenges for mAb-Based Therapeutics.
Antibodies,
Vol. 2,
Issue. 3,
p.
452.
TU, YUE
CHENG, SHIXIANG
ZHANG, SAI
SUN, HONGTAO
and
XU, ZHONGWEI
2013.
Vincristine induces cell cycle arrest and apoptosis in SH-SY5Y human neuroblastoma cells.
International Journal of Molecular Medicine,
Vol. 31,
Issue. 1,
p.
113.
Kwon, Young Hwi
Bishayee, Kausik
Rahman, Ataur
Hong, Jae Seung
Lim, Soon-Sung
and
Huh, Sung-Oh
2015.
Morus alba Accumulates Reactive Oxygen Species to Initiate Apoptosis via FOXO-Caspase 3-Dependent Pathway in Neuroblastoma Cells.
Molecules and Cells,
Vol. 38,
Issue. 7,
p.
630.
Hegde, Meenakshi
Moll, Alexander J.
Byrd, Tiara T.
Louis, Chrystal U.
and
Ahmed, Nabil
2015.
Cellular immunotherapy for pediatric solid tumors.
Cytotherapy,
Vol. 17,
Issue. 1,
p.
3.
Neagu, Monica
Constantin, Carolina
Tampa, Mircea
Matei, Clara
Lupu, Andreea
Manole, Emilia
Ion, Rodica-Mariana
Fenga, Concettina
and
Tsatsakis, Aristidis M.
2016.
Toxicological and efficacy assessment of post-transition metal (Indium) phthalocyanine for photodynamic therapy in neuroblastoma.
Oncotarget,
Vol. 7,
Issue. 43,
p.
69718.
Gur, Hazal
Ozen, Fatih
Can Saylan, Cemil
and
Atasever-Arslan, Belkis
2017.
Dinutuximab in the Treatment of High-Risk Neuroblastoma in Children.
Clinical Medicine Insights: Therapeutics,
Vol. 9,
Issue. ,
p.
1179559X1771910.
Mei, Zhengrong
Yan, Pengke
Wang, Ying
Liu, Shaozhi
and
He, Fang
2018.
Knockdown of zinc transporter ZIP8 expression inhibits neuroblastoma progression and metastasis in�vitro.
Molecular Medicine Reports,
Bao, Juntao
Zhang, Shufeng
Meng, Qinglei
and
Qin, Tao
2020.
SNHG16 Silencing Inhibits Neuroblastoma Progression by Downregulating HOXA7 via Sponging miR-128-3p.
Neurochemical Research,
Vol. 45,
Issue. 4,
p.
825.
Furman, Wayne L
2021.
Monoclonal Antibody Therapies for High Risk Neuroblastoma.
Biologics: Targets and Therapy,
Vol. Volume 15,
Issue. ,
p.
205.